|
|
D Rajotte, W Arap, M Hagedorn, E Koivunen, R Pasqualini, E Ruoslahti
J Clin Invest. 1998;
102(2):430
doi:10.1172/JCI3008
Abstract |
Full text
| PDF

V
ascular beds are known to differ in structure and metabolic function, but less is known about their molecular diversity. We have studied organ-specific molecular differences of the endothelium in various tissues by using in vivo screening of peptide libraries expressed on the surface of a bacteriophage. We report here that targeting of a large number of tissues with this method yielded, in each case, phage that homed selectively to the targeted organ. Different peptide motifs were recovered from each of these tissues. The enrichment in homing to the target organs relative to an unselected phage was 3-35-fold. Peptide sequences that conferred selective phage homing to the vasculature of lung, skin, and pancreas were characterized in detail. Immunohistochemistry showed that the phage localized in the blood vessels of their target organ. When tested, the phage homing was blocked in the presence of the cognate peptide. By targeting several tissues and by showing that specific homing could be achieved in each case, we provide evidence that organ- and tissue-specific molecular heterogeneity of the vasculature is a general, perhaps even universal, phenomenon. Our results also show that these molecular differences can serve as molecular addresses.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(117)
| Title and authors |
Publication |
Year |
Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity
Ping Wu, Jari Leinonen, Erkki Koivunen, Hilkka Lankinen, Ulf-Hakan Stenman
|
Eur J Biochem
|
2000 |
Targeting tumor vasculature with homing peptides from phage display
Erkki Ruoslahti
|
Seminars in Cancer Biology
|
2000 |
Hybrid vector designs to control the delivery, fate and expression of transgenes
Paula Y. P. Lam, Xandra O. Breakefield
|
J. Gene Med.
|
2000 |
Angiogenesis - Research Frontiers. A Basic Science Conference of the New York Academy of Medicine
Laura Sepp-Lorenzino, Bo-Sheng Pan
|
Expert Opin. Investig. Drugs
|
2000 |
Is angiogenesis inhibition the Holy Grail of cancer therapy?
Thomas Boehm-Viswanathan
|
Current Opinion in Oncology
|
2000 |
The use of phage display for the development of tumour targeting agents
Fredrik Nilsson, Lorenzo Tarli, Francesca Viti, Dario Neri
|
Advanced Drug Delivery Reviews
|
2000 |
A Novel Approach for the Identification of Unique Tumor Vasculature Binding Peptides Using an E. coli Peptide Display Library
Charles K. Brown, Ruth A. Modzelewski, Candace S. Johnson, Michael K. K. Wong
|
Annals of Surgical Oncology
|
2000 |
An Address System in the Vasculature of Normal Tissues and Tumors
E. Ruoslahti, D. Rajotte
|
Annu. Rev. Immunol.
|
2000 |
Molecular Adaptors for Vascular-Targeted Adenoviral Gene Delivery
Martin Trepel, Mirta Grifman, Matthew D. Weitzman, Renata Pasqualini
|
Human Gene Therapy
|
2000 |
Labeling and distribution of linear peptides identified using in vivo phage display selection for tumors
Stephen J Kennel, Saed Mirzadeh, Gregory B Hurst, Linda J Foote, Trish K Lankford, Kirsten A Glowienka, Lara L Chappell, Julie R Kelso, Sandra M Davern, Ahmad Safavy
|
Nuclear Medicine and Biology
|
2000 |
|